Tuesday, November 14, 2023, is World Diabetes Day. Diabetes is a disease that occurs when the level of glucose in your blood (blood sugar) is too high. Currently, one in ten adults have diabetes worldwide and more than 90 percent are diagnosed with Type 2 diabetes.

Zhiqiang Lin, Ph.D., assistant professor of biomedical research and translational medicine at Masonic Medical Research Institute (MMRI) and his laboratory are doing critical diabetes research aimed at restoring the metabolism balance in patients with obesity.

“Obesity is one of the triggers for having Type 2 diabetes,” said Dr. Lin. “The goal of my laboratory is to lower the risk of Type 2 diabetes by reducing body weight. We believe that our research will yield new treatment schemes to improve the quality of life for patients with Type 2 diabetes.”

Dr. Lin has been awarded a patent for reducing body weight and is preparing to file a second patent for treating non-alcoholic steatohepatitis (fatty liver disease), which is prevalent in 70 percent of patients with Type 2 diabetes.

To learn more about the research at MMRI visit mmri.edu.

PLATINUM INVESTORS